Skip to main content

Help alleviate CSID symptoms.

Prescribe Sucraid®.1

The only FDA-approved enzyme replacement therapy indicated for the treatment of sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency (CSID), in adult and pediatric patients 5 months of age and older.1

Person cutting up carrots on a cutting board on a wooden table, amongst other vegetables such as cucumbers and radishes

In clinical trials, 81% of patients became asymptomatic with Sucraid®.2*

*Patients who took Sucraid® with each meal were considered asymptomatic if they reported no GI symptoms for at least 7 of the 10 study days.2

How to Order

In clinical trials, 81% of patients became asymptomatic with Sucraid®.2*

*Patients who took Sucraid® with each meal were considered asymptomatic if they reported no GI symptoms for at least 7 of the 10 study days.2

How to Order

How Sucraid® Works

Sucraid®: The mechanism of action.

The active ingredient in Sucraid® is sacrosidase, which is a sucrase enzyme replacement. It splits sucrose into glucose and fructose, which facilitates absorption of both into the bloodstream from the small intestine.1 Although Sucraid® provides replacement therapy for the deficient sucrase, it does not provide specific replacement therapy for the deficient isomaltase.

Dosage Information

Recommended dosage of Sucraid®.

Each dose should be diluted in 4 ounces of water, milk, or infant formula, and can be measured with the provided 1-mL measuring scoop.1

1 mL (8,500 IU; one full measuring scoop) per meal or snack for infants, toddlers, and small children weighing up to 15 kg (33 lb)1

2 mL (17,000 IU; two full measuring scoops) per meal or snack for older children and adults weighing over 15 kg (33 lb)1

Sucraid Bottle Icon See Important Safety Information and Prescribing Information. https://csid.edetail.sucraid.com/#important https://www.sucraidprescribinginformation.com/
  • Half of each Sucraid® dose should be taken before a meal and the other half during a meal.1
  • The beverage or infant formula used to dilute Sucraid® should not be heated, nor should Sucraid® be added to hot beverages, as heat can decrease the potency of the enzyme.1
  • Sucraid® should not be reconstituted or consumed with fruit juices as the acidity may impair enzyme activity.1
  • Sucraid® should be refrigerated at 36°F to 46°F (2°C to 8°C) and protected from heat and light.1
  • Bottles of Sucraid® should be discarded four weeks after first opening due to the potential for bacterial growth.1

Discover the Convenience of the Sucraid® Single-Use Container

Sucraid packaging See Important Safety Information and Prescribing Information. https://csid.edetail.sucraid.com/#important https://www.sucraidprescribinginformation.com/
  • Three-day room temperature stability at 59°F to 77°F (15°C to 25°C)
  • No measuring required. Just twist, squeeze, and mix.
  • Small enough to fit in your pocket.

Recommended dosing for Sucraid® single-use containers:

The contents of the Sucraid® 2-ml single-use container should be diluted in 4 ounces of water, milk, or infant formula. Patients should consume:

  • All of the mixed solution dose per meal or snack for patients over 33 lb (15 kg) in body weight
  • Half of the mixed solution dose per meal or snack for patients 33 lb (15 kg) and less
  • For patients 33 lb (15 kg) and less using the Sucraid® 2-ml single-use container, the second half of the mixed solution should be refrigerated and discarded if not used within 24 hours

See prescribing information for complete dosing instructions.

Meet the Sucraid® Patients

Hear more about Sucraid® from the patients who take it.

Quotation mark

[Now] I can eat more and not experience symptoms, so I don’t dislike eating. [CSID] is a disease that can be tested for, and can be managed.

Stephanie

Play Video
Play Video
Quotation mark

Addie started Sucraid® when she was 21 months old. For us, it was an opportunity to see hope. There’s a light at the end of this tunnel. She’s going to be okay.

Addie’s Parents

Individual results may vary.

Play Video
Play Video
Quotation mark

It came back that James had CSID… After we got a prescription for Sucraid®… we saw symptoms improving. Over time he was symptom-free.

James’s Parents

Individual results may vary.

Play Video
Play Video

These statements reflect individual experiences and should not be used as a substitute for talking with your doctor about whether Sucraid® is right for you. Your doctor can discuss the benefits and risks with you. Each patient experience is unique and QOL Medical, LLC does not provide any warranty or guarantee as to the response a patient will have to Sucraid®.

How to Order
References
  1. Sucraid® [package insert]. Vero Beach, FL: QOL Medical, LLC; 2024.
  2. Treem WR, McAdams L, Stanford L, Kastoff G, Justinich C, Hyams J. Sacrosidase therapy for congenital sucrase-isomaltase deficiency. J Pediatr Gastroenterol Nutr. 1999;28(2):137-42. doi:10.1097/00005176-199902000-00008

Important Safety Information for Sucraid® (sacrosidase) Oral Solution

  • Do not prescribe Sucraid® to patients known to be hypersensitive to yeast, yeast products, papain, or glycerin (glycerol).
  • Sucraid® may cause a serious allergic reaction. Patients should stop taking Sucraid® and get emergency help immediately if any of the following side effects occur: difficulty breathing, wheezing, or swelling of the face. Care should be taken when administering initial doses of Sucraid® to observe any signs of acute hypersensitivity reaction.
  • Although Sucraid® provides replacement therapy for the deficient sucrase, it does not provide specific replacement therapy for the deficient isomaltase.
  • Adverse reactions as a result of taking Sucraid® may include worse abdominal pain, vomiting, nausea, diarrhea, constipation, difficulty sleeping, headache, nervousness, and dehydration.
  • Before prescribing Sucraid® to diabetic patients, the physician should consider that Sucraid® will enable sucrose hydrolysis and the absorption of those hydrolysis products, glucose and fructose.
  • The effects of Sucraid® have not been evaluated in patients with secondary (acquired) disaccharidase deficiency.
  • DO NOT HEAT SOLUTIONS CONTAINING SUCRAID®. Do not put Sucraid® in warm or hot fluids. Do not reconstitute or consume Sucraid® with fruit juice since the acidity of the juice may reduce the enzyme activity of Sucraid®. Half of the reconstituted Sucraid® should be taken at the beginning of the meal or snack and the other half during the meal or snack.
  • Sucraid® should be refrigerated at 36°F-46°F (2°C-8°C) and should be protected from heat and light; single-use containers can be removed from refrigeration and stored at 59°F-77°F (15°C-25°C) for up to 3 days (72 hours). Refer to Instructions for Use for full information on how to take Sucraid®.

Indication

Sucraid® (sacrosidase) Oral Solution is indicated for the treatment of sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency (CSID), in adult and pediatric patients 5 months of age and older.

Please see full Prescribing Information.

Sucraid Sacrosidase Oral Solution | HCP Logo See Important Safety Information and Prescribing Information. https://csid.edetail.sucraid.com/#important https://www.sucraidprescribinginformation.com/

Address

3405 Ocean Drive
Vero Beach, FL 32963

Connect

1 800 705 1962
info@sucraid.com

©  2025 QOL Medical, LLC

This Site is for U.S. Residents Only

Privacy Policy

Terms & Conditions

Do Not Sell/Share My Personal Information

IMPORTANT SAFETY INFORMATION:

Important Safety Information for Sucraid® (sacrosidase) Oral Solution

  • Do not prescribe Sucraid® to patients known to be hypersensitive to yeast, yeast products, papain, or glycerin (glycerol).
  • Sucraid® may cause a serious allergic reaction. Patients should stop taking Sucraid® and get emergency help immediately if any of the following side effects occur: difficulty breathing, wheezing, or swelling of the face. Care should be taken when administering initial doses of Sucraid® to observe any signs of acute hypersensitivity reaction.
  • Although Sucraid® provides replacement therapy for the deficient sucrase, it does not provide specific replacement therapy for the deficient isomaltase.
  • Adverse reactions as a result of taking Sucraid® may include worse abdominal pain, vomiting, nausea, diarrhea, constipation, difficulty sleeping, headache, nervousness, and dehydration.
  • Before prescribing Sucraid® to diabetic patients, the physician should consider that Sucraid® will enable sucrose hydrolysis and the absorption of those hydrolysis products, glucose and fructose.
  • The effects of Sucraid® have not been evaluated in patients with secondary (acquired) disaccharidase deficiency.
  • DO NOT HEAT SOLUTIONS CONTAINING SUCRAID®. Do not put Sucraid® in warm or hot fluids. Do not reconstitute or consume Sucraid® with fruit juice since the acidity of the juice may reduce the enzyme activity of Sucraid®. Half of the reconstituted Sucraid® should be taken at the beginning of the meal or snack and the other half during the meal or snack.
  • Sucraid® should be refrigerated at 36°F-46°F (2°C-8°C) and should be protected from heat and light; single-use containers can be removed from refrigeration and stored at 59°F-77°F (15°C-25°C) for up to 3 days (72 hours). Refer to Instructions for Use for full information on how to take Sucraid®.

Indication

Sucraid® (sacrosidase) Oral Solution is indicated for the treatment of sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency (CSID), in adult and pediatric patients 5 months of age and older.